Status:

COMPLETED

Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer

Lead Sponsor:

Eastern Hepatobiliary Surgery Hospital

Conditions:

Hepatocellular Carcinoma

Eligibility:

All Genders

20-60 years

Phase:

NA

Brief Summary

In this study, we intend to divide the subjects who have been confirmed recurrent HCC into two groups: Group A: treatment with pure surgery or Group B: treatment with pure radio frequency. We will com...

Detailed Description

The recurrence and metastasis of primary liver cancer (PLC) have always been a tough problem for surgeons. Gu Hong-guang reported the five years recurrence rate in PLC subjects reached 75\~100%, among...

Eligibility Criteria

Inclusion

  • 20\~60 years old;
  • diagnosed HCC pathologically, and confirmed recurrent HCC through ultrasonic B, CT, MRI or DSA test;
  • has a good condition in vital organs such as heart, lung, and kidney;
  • has a good liver function: Child A level, or nearly A level after hepatoprotection treatment;
  • solitary small cancer focus (diameter \<5cm), or the number of recurrent HCC focus is no more than three and all of them grow in the same lobe of liver;
  • without jaundice (not including jaundice in the bile ducts), without ascites or extensive metastasis outside the liver;
  • without invasion to portal vein.

Exclusion

  • subjects refuse to participate in this study;
  • subjects cannot be followed up regularly;
  • subjects with severe heart, lung, kidney diseases;
  • subjects with liver CP level B or C, and serum creatinine ≥2×ULN;
  • subjects with severe bone marrow depression, such as neutrophil counting is lower than 1.5 × 109.

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00822562

Start Date

January 1 2009

End Date

December 1 2010

Last Update

April 1 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Eastern Hepatobiliary Surgery Hospital

Shanghai, Shanghai Municipality, China, 200438